Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Apr 15;363(Pt 2):253–262. doi: 10.1042/0264-6021:3630253

Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin.

George N Marchenko 1, Natalia D Marchenko 1, Jay Leng 1, Alex Y Strongin 1
PMCID: PMC1222473  PMID: 11931652

Abstract

A novel matrix metalloproteinase-26 (MMP-26) is known to be specifically expressed in epithelial carcinomas. To facilitate studies of MMP-26 transcriptional regulation, we have cloned and characterized a 1 kb 5'-flanking region of the human MMP-26 gene. Altogether, our findings indicate that the MMP-26 promoter has distinctive structural and functional features among MMP genes. An unusual polyadenylation site proximal to the transcription-factor-binding sites protects transcription of the MMP-26 gene from the upstream promoters and represents a part of the stringent transcriptional regulation of the gene. The MMP-26 gene has a consensus TATA-box and one transcriptional start site located 60 and 35 nucleotides upstream of the translational start site, respectively. The MMP-26 promoter was able to drive luciferase expression in human A549 lung carcinoma, HT1080 fibrosarcoma and HEK293 embryonic kidney cells. The basal transcription efficiency of the MMP-26 promoter is relatively low, thereby explaining the minute expression of the gene in most cells and tissues. When compared with other MMP genes, the MMP-26 promoter contains binding sites for a few transcription factors. Sequential deletion and mutation analysis, and electrophoretic mobility-shift assay have identified the T-cell factor-4 (Tcf-4) motif and the activator protein-1 site as the major regulatory elements of the MMP-26 promoter. Since previous studies have established that the Tcf-4 transcription factor is subjected exclusively to regulation through the beta-catenin/E(epithelial)-cadherin pathway, this implies the specific expression of MMP-26 in cancer cells of epithelial origin.

Full Text

The Full Text of this article is available as a PDF (285.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker N., Clevers H. Catenins, Wnt signaling and cancer. Bioessays. 2000 Nov;22(11):961–965. doi: 10.1002/1521-1878(200011)22:11<961::AID-BIES1>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  2. Behre G., Smith L. T., Tenen D. G. Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation. Biotechniques. 1999 Jan;26(1):24-6, 28. doi: 10.2144/99261bm03. [DOI] [PubMed] [Google Scholar]
  3. Belsham D. D., Mellon P. L. Transcription factors Oct-1 and C/EBPbeta (CCAAT/enhancer-binding protein-beta) are involved in the glutamate/nitric oxide/cyclic-guanosine 5'-monophosphate-mediated repression of mediated repression of gonadotropin-releasing hormone gene expression. Mol Endocrinol. 2000 Feb;14(2):212–228. doi: 10.1210/mend.14.2.0418. [DOI] [PubMed] [Google Scholar]
  4. Brabletz T., Jung A., Dag S., Hlubek F., Kirchner T. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999 Oct;155(4):1033–1038. doi: 10.1016/s0002-9440(10)65204-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000 Mar 7;1477(1-2):267–283. doi: 10.1016/s0167-4838(99)00279-4. [DOI] [PubMed] [Google Scholar]
  6. Crawford H. C., Fingleton B. M., Rudolph-Owen L. A., Goss K. J., Rubinfeld B., Polakis P., Matrisian L. M. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene. 1999 May 6;18(18):2883–2891. doi: 10.1038/sj.onc.1202627. [DOI] [PubMed] [Google Scholar]
  7. Crawford H. C., Fingleton B., Gustavson M. D., Kurpios N., Wagenaar R. A., Hassell J. A., Matrisian L. M. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol. 2001 Feb;21(4):1370–1383. doi: 10.1128/MCB.21.4.1370-1383.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Curran S., Murray G. I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 2000 Aug;36(13 Spec No):1621–1630. doi: 10.1016/s0959-8049(00)00156-8. [DOI] [PubMed] [Google Scholar]
  9. Grentzmann G., Ingram J. A., Kelly P. J., Gesteland R. F., Atkins J. F. A dual-luciferase reporter system for studying recoding signals. RNA. 1998 Apr;4(4):479–486. [PMC free article] [PubMed] [Google Scholar]
  10. He C. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett. 1996 Sep 10;106(2):185–191. doi: 10.1016/0304-3835(96)04318-2. [DOI] [PubMed] [Google Scholar]
  11. Huber A. H., Weis W. I. The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell. 2001 May 4;105(3):391–402. doi: 10.1016/s0092-8674(01)00330-0. [DOI] [PubMed] [Google Scholar]
  12. Illman S. A., Keski-Oja J., Lohi J. Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene. 2001 Sep 5;275(1):185–194. doi: 10.1016/s0378-1119(01)00664-3. [DOI] [PubMed] [Google Scholar]
  13. Kolligs F. T., Hu G., Dang C. V., Fearon E. R. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol. 1999 Aug;19(8):5696–5706. doi: 10.1128/mcb.19.8.5696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lohi J., Lehti K., Valtanen H., Parks W. C., Keski-Oja J. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene. 2000 Jan 25;242(1-2):75–86. doi: 10.1016/s0378-1119(99)00549-1. [DOI] [PubMed] [Google Scholar]
  15. Lohi J., Wilson C. L., Roby J. D., Parks W. C. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem. 2000 Dec 19;276(13):10134–10144. doi: 10.1074/jbc.M001599200. [DOI] [PubMed] [Google Scholar]
  16. Lorenz W. W., Cormier M. J., O'Kane D. J., Hua D., Escher A. A., Szalay A. A. Expression of the Renilla reniformis luciferase gene in mammalian cells. J Biolumin Chemilumin. 1996 Jan-Feb;11(1):31–37. doi: 10.1002/(SICI)1099-1271(199601)11:1<31::AID-BIO398>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  17. Love J. J., Li X., Case D. A., Giese K., Grosschedl R., Wright P. E. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature. 1995 Aug 31;376(6543):791–795. doi: 10.1038/376791a0. [DOI] [PubMed] [Google Scholar]
  18. Marchenko G. N., Ratnikov B. I., Rozanov D. V., Godzik A., Deryugina E. I., Strongin A. Y. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J. 2001 Jun 15;356(Pt 3):705–718. doi: 10.1042/0264-6021:3560705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marchenko G. N., Strongin A. Y. MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene. 2001 Mar 7;265(1-2):87–93. doi: 10.1016/s0378-1119(01)00360-2. [DOI] [PubMed] [Google Scholar]
  20. Massova I., Kotra L. P., Fridman R., Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 1998 Sep;12(12):1075–1095. [PubMed] [Google Scholar]
  21. Mattei M. G., Roeckel N., Olsen B. R., Apte S. S. Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively. Genomics. 1997 Feb 15;40(1):168–169. doi: 10.1006/geno.1996.4559. [DOI] [PubMed] [Google Scholar]
  22. Mueller M. S., Mauch S., Sedlacek R. Structure of the human MMP-19 gene. Gene. 2000 Jul 11;252(1-2):27–37. doi: 10.1016/s0378-1119(00)00236-5. [DOI] [PubMed] [Google Scholar]
  23. Nagase H., Woessner J. F., Jr Matrix metalloproteinases. J Biol Chem. 1999 Jul 30;274(31):21491–21494. doi: 10.1074/jbc.274.31.21491. [DOI] [PubMed] [Google Scholar]
  24. Nelson A. R., Fingleton B., Rothenberg M. L., Matrisian L. M. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000 Mar;18(5):1135–1149. doi: 10.1200/JCO.2000.18.5.1135. [DOI] [PubMed] [Google Scholar]
  25. Park H. I., Ni J., Gerkema F. E., Liu D., Belozerov V. E., Sang Q. X. Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem. 2000 Jul 7;275(27):20540–20544. doi: 10.1074/jbc.M002349200. [DOI] [PubMed] [Google Scholar]
  26. Pendás A. M., Balbín M., Llano E., Jiménez M. G., López-Otín C. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics. 1997 Mar 1;40(2):222–233. doi: 10.1006/geno.1996.4554. [DOI] [PubMed] [Google Scholar]
  27. Price S. J., Greaves D. R., Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2000 Dec 12;276(10):7549–7558. doi: 10.1074/jbc.M010242200. [DOI] [PubMed] [Google Scholar]
  28. Rastegar M., Rousseau G. G., Lemaigre F. P. CCAAT/enhancer-binding protein-alpha is a component of the growth hormone-regulated network of liver transcription factors. Endocrinology. 2000 May;141(5):1686–1692. doi: 10.1210/endo.141.5.7478. [DOI] [PubMed] [Google Scholar]
  29. Roose J., Huls G., van Beest M., Moerer P., van der Horn K., Goldschmeding R., Logtenberg T., Clevers H. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 1999 Sep 17;285(5435):1923–1926. doi: 10.1126/science.285.5435.1923. [DOI] [PubMed] [Google Scholar]
  30. Schreiber E., Matthias P., Müller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989 Aug 11;17(15):6419–6419. doi: 10.1093/nar/17.15.6419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Simcha I., Kirkpatrick C., Sadot E., Shtutman M., Polevoy G., Geiger B., Peifer M., Ben-Ze'ev A. Cadherin sequences that inhibit beta-catenin signaling: a study in yeast and mammalian cells. Mol Biol Cell. 2001 Apr;12(4):1177–1188. doi: 10.1091/mbc.12.4.1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Skalnik D. G., Strauss E. C., Orkin S. H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J Biol Chem. 1991 Sep 5;266(25):16736–16744. [PubMed] [Google Scholar]
  33. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 2000 Dec;10(6):415–433. doi: 10.1006/scbi.2000.0379. [DOI] [PubMed] [Google Scholar]
  34. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999 Apr 1;398(6726):422–426. doi: 10.1038/18884. [DOI] [PubMed] [Google Scholar]
  35. Valsamakis A., Zeichner S., Carswell S., Alwine J. C. The human immunodeficiency virus type 1 polyadenylylation signal: a 3' long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2108–2112. doi: 10.1073/pnas.88.6.2108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vincenti M. P. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol. 2001;151:121–148. doi: 10.1385/1-59259-046-2:121. [DOI] [PubMed] [Google Scholar]
  37. Westermarck J., Kähäri V. M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999 May;13(8):781–792. [PubMed] [Google Scholar]
  38. Williamson E. A., Xu H. N., Gombart A. F., Verbeek W., Chumakov A. M., Friedman A. D., Koeffler H. P. Identification of transcriptional activation and repression domains in human CCAAT/enhancer-binding protein epsilon. J Biol Chem. 1998 Jun 12;273(24):14796–14804. doi: 10.1074/jbc.273.24.14796. [DOI] [PubMed] [Google Scholar]
  39. Ye S. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 2000 Dec;19(7):623–629. doi: 10.1016/s0945-053x(00)00102-5. [DOI] [PubMed] [Google Scholar]
  40. de Coignac A. B., Elson G., Delneste Y., Magistrelli G., Jeannin P., Aubry J. P., Berthier O., Schmitt D., Bonnefoy J. Y., Gauchat J. F. Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem. 2000 Jun;267(11):3323–3329. doi: 10.1046/j.1432-1327.2000.01363.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES